X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Colgate - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs COLGATE - Comparison Results

COLGATE 
   Change

Colgate is present in oral care, personal care and household care products with oral care contributing more than 90% to overall revenues. Colgate dominates in this core business with market shares of 54.5% in toothpastes and 38.2% in toothbrushes. Th... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES COLGATE AMAR REMEDIES/
COLGATE
 
P/E (TTM) x -0.5 50.3 - View Chart
P/BV x 0.1 28.5 0.2% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 AMAR REMEDIES   COLGATE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
COLGATE
Mar-16
AMAR REMEDIES/
COLGATE
5-Yr Chart
Click to enlarge
High Rs1642,198 7.5%   
Low Rs86791 10.9%   
Sales per share (Unadj.) Rs261.6153.0 171.0%  
Earnings per share (Unadj.) Rs17.421.2 82.1%  
Cash flow per share (Unadj.) Rs22.325.3 88.1%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs100.737.5 268.7%  
Shares outstanding (eoy) m26.16271.99 9.6%   
Bonus/Rights/Conversions -B1:1-  
Price / Sales ratio x0.59.8 4.9%   
Avg P/E ratio x7.270.5 10.2%  
P/CF ratio (eoy) x5.659.1 9.5%  
Price / Book Value ratio x1.239.9 3.1%  
Dividend payout %047.2 0.0%   
Avg Mkt Cap Rs m3,270406,516 0.8%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m1632,698 6.0%   
Avg. sales/employee Rs ThNM18,271.7-  
Avg. wages/employee Rs ThNM1,184.4-  
Avg. net profit/employee Rs ThNM2,530.8-  
INCOME DATA
Net Sales Rs m6,84441,623 16.4%  
Other income Rs m21396 5.3%   
Total revenues Rs m6,86542,019 16.3%   
Gross profit Rs m1,1319,313 12.1%  
Depreciation Rs m1281,114 11.5%   
Interest Rs m3980-   
Profit before tax Rs m6268,595 7.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-313 16.0%   
Tax Rs m1212,516 4.8%   
Profit after tax Rs m4555,765 7.9%  
Gross profit margin %16.522.4 73.9%  
Effective tax rate %19.329.3 66.0%   
Net profit margin %6.613.9 48.0%  
BALANCE SHEET DATA
Current assets Rs m4,9047,743 63.3%   
Current liabilities Rs m3,5818,365 42.8%   
Net working cap to sales %19.3-1.5 -1,293.2%  
Current ratio x1.40.9 147.9%  
Inventory Days Days12426 484.2%  
Debtors Days Days1009 1,124.8%  
Net fixed assets Rs m1,68910,865 15.5%   
Share capital Rs m262272 96.3%   
"Free" reserves Rs m2,3589,923 23.8%   
Net worth Rs m2,63510,195 25.8%   
Long term debt Rs m5070-   
Total assets Rs m6,86219,437 35.3%  
Interest coverage x2.6NM-  
Debt to equity ratio x0.20-  
Sales to assets ratio x1.02.1 46.6%   
Return on assets %12.429.7 41.9%  
Return on equity %17.356.5 30.5%  
Return on capital %31.081.2 38.2%  
Exports to sales %4.01.9 206.8%   
Imports to sales %08.7 0.0%   
Exports (fob) Rs m273803 34.0%   
Imports (cif) Rs mNA3,622 0.0%   
Fx inflow Rs m2731,075 25.4%   
Fx outflow Rs m26,924 0.0%   
Net fx Rs m271-5,850 -4.6%   
CASH FLOW
From Operations Rs m-3136,729 -4.6%  
From Investments Rs m-489-2,366 20.6%  
From Financial Activity Rs m769-3,758 -20.5%  
Net Cashflow Rs m-33605 -5.4%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 51.0 -  
Indian inst/Mut Fund % 9.2 7.0 131.4%  
FIIs % 0.0 20.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 22.1 295.5%  
Shareholders   13,061 131,569 9.9%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ INDUSTRIES  BATA INDIA  P&G HYGIENE  GILLETTE INDIA  K.S.OILS LTD  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Colgate: Competition Impacts Volume Growth (Quarterly Results Update - Detailed)

Nov 25, 2016

Colgate-Palmolive (India) has announced the second quarter results financial year 2016-2017 (2QFY17). While the topline increased by 9.5% YoY, the bottomline has increased by 15.6% YoY.

Colgate: Margins come under pressure (Quarterly Results Update - Detailed)

Oct 4, 2016

Colgate-Palmolive (India) has announced the first quarter results financial year 2016-2017 (1QFY17). While the topline increased by 12.4% YoY, the bottomline has increased by 8.4% YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS